MARSHALL WACE, LLP - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 228 filers reported holding CONMED CORP in Q1 2019. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of CONMED CORP
ValueSharesWeighting
Q3 2023$1,465,150
+129.2%
14,528
+136.0%
0.00%
+200.0%
Q1 2023$639,362
-92.6%
6,156
-94.9%
0.00%
-98.4%
Q2 2020$8,689,000
+3.4%
120,705
-17.8%
0.06%
-27.4%
Q1 2020$8,407,000
-38.4%
146,807
-7.9%
0.08%
-25.0%
Q2 2019$13,642,000
-79.4%
159,433
-80.0%
0.11%
-64.2%
Q1 2019$66,332,000
+544.9%
797,444
+397.7%
0.31%
+198.1%
Q4 2018$10,286,000
+1797.8%
160,222
+1310.2%
0.10%
+1400.0%
Q3 2015$542,000
-66.6%
11,362
-69.1%
0.01%
-70.8%
Q2 2014$1,622,00036,7310.02%
Other shareholders
CONMED CORP shareholders Q1 2019
NameSharesValueWeighting ↓
Iron Triangle Partners LP 190,000$24,858,0003.57%
Ranger Investment Management 253,789$33,203,0001.77%
EARNEST PARTNERS LLC 1,603,130$209,737,0001.28%
Penn Capital Management Company, LLC 92,086$12,048,0001.22%
Champlain Investment Partners, LLC 1,492,419$195,253,0000.94%
MOODY ALDRICH PARTNERS LLC 53,257$6,968,0000.88%
Hood River Capital Management LLC 215,384$28,179,0000.87%
OAK RIDGE INVESTMENTS LLC 71,880$9,404,0000.83%
WAFRA INC. 138,542$18,125,0000.66%
EPIQ PARTNERS, LLC 10,463$1,369,0000.63%
View complete list of CONMED CORP shareholders